Language

News topic

Active ingredient Mitomycin

Current shortage notices for the active ingredient Mitomycin, structured by product, country and reporting period.

2 notices

← All shortages

What the Mitomycin notices indicate for the supply chain

The 2 consolidated notices from Belgium, Germany are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.

GDP-capable pharmaceutical storage in Cheb

Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.

Belgium

Mitomycin Accord Healthcare 10 mg inj./inf. sol. (pwdr.)/i.vesic. sol. (pwdr.) i.v. vial 5 x 10 mg

Active ingredient: Mitomycin

View notice details →

Plan supply. Connect sourcing and warehousing.

For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.